{
      "Rank": 269,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "According to Diagnosis and Clinical Management of Pneumonia caused by 2019-nCoV Infection(Trial Version 4), patients enrolled will be divided to serious pneumonia group or critical pneumonia group. All subjects will receive UC-MSCs 3.3 * 107 cell number / 50ml / bag, 3 bags each time. And UC-MSCs will be infused intravenously on the 1st, 3rd, 5th, and 7th days after enrollment, 1 time each day. The efficacy and safety of the treatment, patients' adverse reactions will be monitored."
      ],
      "ArmGroupInterventionName": [
            "Biological: UC-MSCs"
      ],
      "ArmGroupLabel": [
            "pneumonia"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT04269525"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Serious Pneumonia and Critical Pneumonia caused by the 2019-nCOV infection greatly threats patients' life, UC-MSCs treatment has been proved to play a role in curing multiple diseases. And this study is conducted to find out whether or not it will function in 2019-nCOV infection Pneumonia."
      ],
      "BriefTitle": [
            "Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia"
      ],
      "CentralContactEMail": [
            "znyylcsy@126.com",
            "pengzy5@hotmail.com"
      ],
      "CentralContactName": [
            "XingHuan Wang, professor",
            "ZhiYong Peng, professor"
      ],
      "CentralContactPhone": [
            "18971387168",
            "18672396028"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "UNKNOWN"
      ],
      "CollaboratorName": [
            "Tuohua Biological Technology Co. Ltd"
      ],
      "CompletionDate": [
            "December 30, 2020"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Pneumonia, Viral",
            "Pneumonia, Ventilator-Associated"
      ],
      "ConditionAncestorId": [
            "D000012141",
            "D000007239",
            "D000008171",
            "D000012140",
            "D000014777",
            "D000077299",
            "D000003428",
            "D000007049",
            "D000020969",
            "D000010335"
      ],
      "ConditionAncestorTerm": [
            "Respiratory Tract Infections",
            "Infections",
            "Lung Diseases",
            "Respiratory Tract Diseases",
            "Virus Diseases",
            "Healthcare-Associated Pneumonia",
            "Cross Infection",
            "Iatrogenic Disease",
            "Disease Attributes",
            "Pathologic Processes"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC01",
            "BC08",
            "All",
            "BC23",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Infections",
            "Respiratory Tract (Lung and Bronchial) Diseases",
            "All Conditions",
            "Symptoms and General Pathology",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Pneumonia",
            "Pneumonia, Ventilator-Associated",
            "Pneumonia, Viral"
      ],
      "ConditionBrowseLeafId": [
            "M2562",
            "M9435",
            "M5520",
            "M13056",
            "M26598",
            "M19643",
            "M13066",
            "M14130",
            "M10320",
            "M14129",
            "M16674",
            "M1752",
            "M5794",
            "M9251",
            "M21853",
            "T4202"
      ],
      "ConditionBrowseLeafName": [
            "COVID-19",
            "Infections",
            "Communicable Diseases",
            "Pneumonia",
            "Pneumonia, Ventilator-Associated",
            "Coronavirus Infections",
            "Pneumonia, Viral",
            "Respiratory Tract Infections",
            "Lung Diseases",
            "Respiratory Tract Diseases",
            "Virus Diseases",
            "Healthcare-Associated Pneumonia",
            "Cross Infection",
            "Iatrogenic Disease",
            "Disease Attributes",
            "Oculocerebral Syndrome With Hypopigmentation"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "low",
            "low",
            "high",
            "high",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000011014",
            "D000011024",
            "D000053717"
      ],
      "ConditionMeshTerm": [
            "Pneumonia",
            "Pneumonia, Viral",
            "Pneumonia, Ventilator-Associated"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [
            "reaching the criteria of pneumonia according to Diagnosis and Clinical Management of Pneumonia caused by 2019-nCoV Infection(Trial Version 4)"
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Prevention"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Serious Pneumonia and Critical Pneumonia caused by the 2019-nCOV infection greatly threats patients' life, UC-MSCs treatment has been proved to play a role in curing multiple diseases. And this study is conducted to find out whether or not it will function in 2019-nCOV infection Pneumonia. And we are going to get the permission of the enrolled patients. Besides the present clinical treatment, UC-MSCs treatment will be applied to those fulfilling the enrollment. After a period of UC-MSCs treatment, the analysis of UC-MSCs treatment will be completed from related aspects."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\n18-80 years old ,no gender restriction\nAccording to Diagnosis and Clinical Management of Pneumonia caused by 2019-nCoV infection(Trial Version 6), patients are diagnosed with severe or critical 2019-nCoV pneumonia\nWomen of childbearing age should have a negative blood pregnancy test before the start of dosing and agree to take effective contraceptive measures during the trial until the last follow-up (28 days)\nPrevious detection of Nucleotide or antibody of 2019-nCoV pneumonia was positive\nVoluntarily participate in this clinical study and sign a written informed consent. If the patient cannot obtain informed consent, he can authorize his legal representative.\n\nExclusion Criteria:\n\nLiver SOFA score of more than 3 points;\nHIV positive\nHighly allergic constitution or history of severe allergies;\nPregnant and lactating women;\nPatients with malignant tumors;\nPatients with previous history of pulmonary embolism;\nParticipating in clinical trials of other drugs within 3 months before enrollment.\nbe thought by researchers to be inappropriate to participate in this clinical study."
      ],
      "EnrollmentCount": [
            "16"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "pneumonia"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "After enrollment, each subject will receive UC-MSCs infusion intravenously on day 1, day 3, day 5, and day 7."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "UC-MSCs"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "2019-nCOV infection",
            "UC-MSCs Treatment"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "July 1, 2020"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "June 29, 2020"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "ZhiYong Peng"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Wuhan"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [
            "XingHuan Wang, professor",
            "ZhiYong Peng, professor",
            "XingHuan Wang",
            "ZhiYong Peng"
      ],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "Zhongnan Hospital of Wuhan University"
      ],
      "LocationState": [
            "Hubei"
      ],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [
            "430000"
      ],
      "MaximumAge": [
            "80 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Clinical Research Regarding the Availability and Safety of UC-MSCs Treatment for Serious Pneumonia and Critical Pneumonia Caused by the 2019-nCOV Infection"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Zhongnan Hospital"
      ],
      "OrgStudyId": [
            "2020002"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Wuhan University"
      ],
      "OverallOfficialName": [
            "XingHuan Wang, professor"
      ],
      "OverallOfficialRole": [
            "Study Chair"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 1, 2020"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "partial arterial oxygen pressure (PaO2) / oxygen concentration (FiO2)"
      ],
      "PrimaryOutcomeMeasure": [
            "Oxygenation index"
      ],
      "PrimaryOutcomeTimeFrame": [
            "on the day 14 after enrollment"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Zhongnan Hospital"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "ZhiYong Peng"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "professor"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor-Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "whether the patient survives",
            "days of the patients in hospital",
            "whether or not the 2019-nCoV antibody is positive",
            "whether or not the 2019-nCoV nucleic acid test is positive",
            "whether lung imaging examinations show the improvement of the pneumonia",
            "counts of white blood cell in a litre of blood",
            "counts of lymphocyte in a litre (L) of blood",
            "procalcitonin in microgram(ug)/L",
            "IL-2 in picogram(pg)/millilitre(mL)",
            "IL-4 in pg/mL",
            "IL-6 in pg/mL",
            "IL-10 in pg/mL",
            "TNF-\u03b1 in nanogram(ng)/L",
            "\u03b3-IFN in a thousand unit (KU)/L",
            "CRP in microgram\uff08\u03bcg\uff09/L",
            "counts of CD4+ T-Lymphocytopenia in litre",
            "counts of CD8+ T-Lymphocytopenia in a litre",
            "counts of NK in a litre"
      ],
      "SecondaryOutcomeMeasure": [
            "28 day mortality",
            "Hospital stay",
            "2019-nCoV antibody test",
            "2019-nCoV nucleic acid test",
            "Improvement of lung imaging examinations",
            "White blood cell count",
            "Lymphocyte count",
            "Procalcitonin",
            "interleukin(IL)-2",
            "IL-4",
            "IL-6",
            "IL-10",
            "tumor necrosis factor(TNF)-\u03b1",
            "\u03b3-interferon(IFN)",
            "C-reactive protein(CRP)",
            "CD4+ T-Lymphocytopenia",
            "CD8+ T-Lymphocytopenia",
            "natural killer cell(NK)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "on the day 28 after enrollment",
            "up to 6 months",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment",
            "on the day 7,14,28 after enrollment"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "February 6, 2020"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "June 2020"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "February 13, 2020"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "February 7, 2020"
      ],
      "StudyFirstSubmitQCDate": [
            "February 12, 2020"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}